The Coronavirus Is No Match Against Sybody 23
The virus that causes COVID-19, SARS-CoV-2, uses its spike protein to gain access to cells, by binding to the ACE2 receptor. Unsurprisingly, stopping the spike protein from latching on to ACE2 has been a major focus in the design and development of COVID-19 therapeutics.
One such approach is by using antibodies (natural immune molecules that attach to pathogens) which have proven to be…